Among the 10 drugs listed, Medicare Part D spent the most on Ozempic, Rybelsus and Wegovy, at $14.43 billion, according to a fact sheet published Friday by the Centers for Medicare & Medicaid ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

Here’s what to know about Ozempic coverage under Medicare and other payment options available to older adults interested in trying it. While Ozempic is approved by the FDA to treat type 2 ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations ...

WASHINGTON — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug manufacturers ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.